9 results
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
Here is a quick ... (HCV) infection ... #DAAs #Antivirals ... #table #treatment ... #Management #Pharmacology
Guide to Treatment of Hepatitis C with Direct Acting Antivirals.

Here is a pocket guide to initial
Here is a pocket ... of HCV with DAAs ... #Management #Pharmacology ... #HepatitisC #HCV ... #Antivirals #Treatment
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... Opportunistic #Infections #OIs ... #HIVAIDS #IDSA ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... Chagas Disease ... Note: Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
used to treat Hepatitis ... Direct-Acting Antivirals ... patients genotype, treatment ... Nomenclature #Classes #DAAs ... #Pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... illness usually is ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Antiviral agents ... recommended for KS treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
Hydroxychloroquine is an antimalarial & DMARD (disease modifying antirheumatic drug). It is currently being discussed as
antimalarial & DMARD (disease ... an experimental prophylaxis ... and treatment for ... skin pigmentation changes ... #Pharmacology #